Insights
Cell and Gene Therapy
![](https://www.ttp.com/wp-content/uploads/2024/07/header-cgt-article-01-122x95.png)
Cell and Gene Therapy
Non-contact cell counting enables in-line, real-time monitoring of manufacturing processes
![](https://www.ttp.com/wp-content/uploads/2024/05/CGT-leaders-dinner-122x95.jpg)
Cell and Gene Therapy
Treatment of chronic conditions is the new frontier for stem cell-derived therapies: Deep phenotyping and manufacturing scale-up key to opening clinic doors, say experts at TTP’s panel discussion
![cancer cells being attacked by T Cells](https://www.ttp.com/wp-content/uploads/2023/11/t-cells-cancer-122x95.jpg)
Cell and Gene Therapy
With personalised cancer vaccines on the rise, is manufacturing scalable yet?
![](https://www.ttp.com/wp-content/uploads/2023/02/image-66-122x95.jpeg)
Life Science
How is cell and gene therapy innovation adapting to a changing investment landscape? Insights from TTP’s Cell & Gene panel event
![](https://www.ttp.com/wp-content/uploads/2022/11/image-7-122x95.jpeg)
Life Science
How can you prove 99.9% reliability? A challenge in automating and scaling cell therapies
![](https://www.ttp.com/wp-content/uploads/2022/11/image-60-122x95.png)
Life Science
What failure rate are we willing to accept in cell therapy manufacture? Insights from medical device development
![](https://www.ttp.com/wp-content/uploads/2022/11/image-62-122x95.png)
Life Science
Special Delivery: can advanced intracellular delivery enable superior cell therapies for solid tumour treatment – and beyond?
![](https://www.ttp.com/wp-content/uploads/2022/11/image-63-122x95.png)
Life Science
Only a ‘click’ away: click chemistry transforms life science applications
![](https://www.ttp.com/wp-content/uploads/2022/11/image-85-122x95.png)
Life Science
Driving Cell Therapy Innovation: Applying Key Lessons from the Evolution and Commercialization of Protein-Based Therapies
![](https://www.ttp.com/wp-content/uploads/2022/11/image-88-122x95.png)
Life Science
Predicting failure rates in cell therapy manufacturing: is one in a million good enough?
![](https://www.ttp.com/wp-content/uploads/2022/11/image-91-122x95.png)
Life Science
How many cells should a therapeutic cell sorter sort? (Part 3)
![](https://www.ttp.com/wp-content/uploads/2022/11/image-99-122x95.png)
Life Science
Who should lead the charge in cell therapy manufacturing?
There are no insights for your current selection. Please select a different industry.